Research on the Coupling of Centralized Drug Procurement based on Blockchain Technology
DOI:
https://doi.org/10.54097/jeer.v3i1.8376Keywords:
Blockchain, Pharmaceutical Supply Chain, Centralized ProcurementAbstract
Centralized drug procurement is an important measure to alleviate the high cost of drugs for the masses. However, due to the difficulties in platform interaction, low transparency, privacy disclosure and other problems of centralized drug procurement, the efficiency of drug circulation is low and violations emerge in an endless stream. Blockchain technology is characterized by decentralization, tamper-proof, autonomy, etc. Combined with the features of numerous participants in centralized drug procurement and large amount of data processing, a framework for centralized drug procurement based on super ledger is built, and identity registration chain code, price negotiation chain code, and contract performance chain code are designed to realize centralized drug procurement autonomy, openness, transparency, and traceability. It aims to improve centralized drug procurement and ensure transparency and accountability throughout the drug supply chain in order to maximize the effect of lower prices brought about by healthcare reform.
Downloads
References
Chen Zhihong, Xu Hong. Interpretation and empirical analysis of China's centralized drug procurement policy [J]. Journal of System Management,2021,30(01):170-179. (in Chinese)
Chen Bo. Improving the government pricing mechanism and promoting the sunshine purchase of drugs -- Rational thinking on the centralized online bidding purchase of drugs in Guangdong medical institutions [J]. Price theory and practice, 2007, No. 282 (12): 22-24. DOI: 10.19851 / j. carol carroll nki cn11-1010 / f 2007.12.010.
Sun Xue, Pu Chuan. Analysis of China's centralized bidding procurement model for drugs [J]. China Pharmacy, 2011, 22 (40): 3766-3769. (in Chinese)
Li Qian, Guan Haijing, Dong Guoqing et al. [J]. Chinese Journal of New Medicine,2016,25(02):129-133.
Yu Changyong. The practical effect and system hidden concern of "4+7" drug belt purchasing [J]. Journal of Southwest University for Nationalities (Humanities and Social Sciences Edition), 20,41(04):34-39.
Wang Zhenping, Fang Rui. Drug purchase of "secondary bargaining" social utility cost study [J]. Journal of price theory and practice, 2014, No. 357 (3): 54-56. DOI: 10.19851 / j. carol carroll nki cn11-1010 / f 2014.03.017.
Ding Jinxi, Tian Ran, Li Wei. Drug centralized purchasing policy under the framework of "one vote" distribution mode study [J]. China's pharmaceutical industry magazine, 2016,47 (7): 952-957. The DOI: 10.16522 / j. carol carroll nki CJPH. 2016. 07.029.
Ding Jinxi, Dong Rui, Li Wei, et al. Evaluation and consideration on the Policy of "Bidding Group" in Chinese drug centralized procurement System -- Based on the statistical analysis of provincial centralized procurement plan in 2016 [J]. Chinese Health Policy Research,2016,9(09):52-59.
Zhou Q. Analysis and reflection on the policy of centralized procurement of drugs with quantity -- based on the perspective of three medical linkage [J]. Medical insurance in China, 2020, No. 143 (8): 22-25. DOI: 10.19546 / j. i SSN. 1674-3830. 2020. 8. 006.
Zhao Bin, Liang Hailun, Zhu Mingjun, et al. Review on the rules of bidding and purchasing subject of Centralized bidding and Purchasing Mechanism for drugs -- Based on the practical experience of different medical security systems in European Union [J]. Chinese Pharmacy,2012,23(12):1087-1091.
Wang Fan, Hou Yanhong. GPO role in medical supply chain analysis [J]. China's pharmaceutical industry magazine, 2016,47 (5): 660-665. The DOI: 10.16522 / j.carol carroll nki CJPH. 2016.05.031.
Wu Hanhong, Zhou Xiao. Bidding competition, enterprise group, and centralized purchasing performance [J]. Journal of economic management, 2017, 33 (05) 6:50-68. The DOI: 10. 19616 / j.carol carroll nki. BMJ. 2017.05.004.
Gu Xin. A new era of China's new health care reform and the new challenges facing the national health insurance bureau [J]. Journal of university, 2019, No. 175 (01): 106-115. The DOI: 10. 16091 / j.carol carroll nki cn32-1308 / c. 2019.01.013.
Chen Zhihong, Xu Hong. Interpretation and empirical analysis of China's centralized drug procurement policy [J]. Journal of System Management,2021,30(01):170-179. (in Chinese)
He Xiaodong, Yi Jizheng, Chen Aibin. Block chain technology application progress and the development tendency of [J]. Journal of world science and technology research and development, 2018, 40 (6): 615-626. The DOI: 10.16507 / j. i SSN. 1006-6055.2018.12.007.
Zhou Yihua, Jia Yuxin, Jia Liyuan, Fang Jiabo, Shi Weimin. Data integrity verification scheme of shared electronic medical record based on red-black tree [J]. Computer Science, 2021, 48 (09):330-336.
Luo Wenjun, Wen Shenglian, Cheng Yu. Electronic medical record sharing scheme based on blockchain [J]. Journal of Computer Applications,2020,40(01):157-161. (In Chinese)
Wang Hui, Zhou Mingming. Security storage model of medical information based on blockchain [J]. Computer Science, 2019, 46(12):174-179.
Xiao Yong, Shen Shaowu. Research on Construction of Chinese Medicinal materials supply traceability system based on blockchain [J]. Shi Zhen Chinese Medicine, 2021, 32(01): 181-183. (In Chinese)
Mueen Uddin."Blockchain Medledger Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry," international Journal of Pharmaceutics 597 (2021).
Bi Ya, Zhou Bei, Leng Kaijun, Wang Cunfa. Pharmaceutical business resources public blockchain based on double-chain architecture [J]. Computer Science,2018,45(02):40-47. (in Chinese)
A. Omar, R. Jayaraman, M. S. Debe, K. Salah, I. Yaqoob and M. Omar, "Automating Procurement Contracts in the Healthcare Supply Chain Using Blockchain Smart Contracts," in IEEE Access, vol. 9, pp. 37397-37409, 2021, doi: 10.1109/ ACCESS. 2021.3062471.










